encyclopedia of medical concepts
ψ 

11-beta-Hydroxysteroid Dehydrogenase Type 2

More information in Books or onNLM PubMed
Definition: An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.      Other names 11beta Hydroxysteroid Dehydrogenase Type 2; 11 beta Hydroxysteroid Dehydrogenase Type 2; 11beta-Hydroxysteroid Dehydrogenase Type 2; 11beta-HSD2 Reductase; 11 beta-Hydroxysteroid Dehydrogenase Type 2; 11 beta-HSD2; 11beta-HSD2
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
HSD11B2 protein, human  EC 1.1.1.146   *11-beta-Hydroxysteroid Dehydrogenase Type 2.

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy